ResearcherUniversity of LouisvilleActive in the last 2 years

Jun Yan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0007-5441-8671; OpenAlex author ID A5039680860; NIH RePORTER profile ID 6983402. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper · 2026: 1 grant

Papers 1

Irreversible Electroporation and Beta-Glucan-Induced Trained Innate Immunity for Treatment of Pancreatic Ductal Adenocarcinoma: A Phase II Study. Last author DOI 10.1097/xcs.0000000000001291 ↗

Grants 1

Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping R01CA278941 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Haixun Guo · 1 shared grant, 2026 · strength 1.26
- Grant Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with… R01CA278941 ↗
Yan Li · 1 shared paper, 2025 · strength 0.25
- Paper Irreversible Electroporation and Beta-Glucan-Induced Trained Innate Immunity for Treatment of Pancreatic Ductal Adenoca… DOI 10.1097/xcs.0000000000001291 ↗
Danial A. Malik · 1 shared paper, 2025 · strength 0.25
- Paper Irreversible Electroporation and Beta-Glucan-Induced Trained Innate Immunity for Treatment of Pancreatic Ductal Adenoca… DOI 10.1097/xcs.0000000000001291 ↗
Robert C.G. Martin · 1 shared paper, 2025 · strength 0.25
- Paper Irreversible Electroporation and Beta-Glucan-Induced Trained Innate Immunity for Treatment of Pancreatic Ductal Adenoca… DOI 10.1097/xcs.0000000000001291 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.